{"id":381764,"date":"2020-11-16T08:57:18","date_gmt":"2020-11-16T13:57:18","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=381764"},"modified":"2020-11-16T08:57:18","modified_gmt":"2020-11-16T13:57:18","slug":"deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/","title":{"rendered":"DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Odonate Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm"},"content":{"rendered":"

<\/p>\n

DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Odonate Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm<\/b><\/p>\n

LOS ANGELES–(BUSINESS WIRE<\/a>)–The Schall Law Firm<\/a>, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Odonate Therapeutics, Inc. (\u201cOdonate\u201d or \u201cthe Company\u201d) (NASDAQ: ODT<\/a>) for violations of the securities laws.\n<\/p>\n

\nThe investigation focuses on whether the Company issued false and\/or misleading statements and\/or failed to disclose information pertinent to investors. Odonate\u2019s tesetaxel treatment was not as safe nor as well-tolerated by patients as was touted by the Company. The cancer treatment\u2019s commercial viability was overstated by the Company. Based on these facts, the Company\u2019s public statements were false and materially misleading throughout the class period. When the market learned the truth about Odonate, investors suffered damages.\n<\/p>\n

\nIf you are a shareholder who suffered a loss, click here to participate<\/a>.\n<\/p>\n

\nWe also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com<\/a>, or by email at brian@schallfirm.com<\/a>.\n<\/p>\n

\nThe Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.\n<\/p>\n

\nThis press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20201116005714\/en\/<\/a><\/span><\/p>\n

\nThe Schall Law Firm
\n
Brian Schall, Esq.
\n
310-301-3335
\n
info@schallfirm.com
\n<\/a>
www.schallfirm.com<\/a><\/p>\n

KEYWORDS:<\/b> California United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Legal Professional Services<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Odonate Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Odonate Therapeutics, Inc. (\u201cOdonate\u201d or \u201cthe Company\u201d) (NASDAQ: ODT) for violations of the securities laws. The investigation focuses on whether the Company issued false and\/or misleading statements and\/or failed to disclose information pertinent to investors. Odonate\u2019s tesetaxel treatment was not as safe nor as well-tolerated by patients as was touted by the Company. The cancer treatment\u2019s commercial viability was overstated by the Company. Based on these facts, the Company\u2019s public statements … <\/p>\n

Continue reading “DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Odonate Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-381764","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nDEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Odonate Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Odonate Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Odonate Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Odonate Therapeutics, Inc. (\u201cOdonate\u201d or \u201cthe Company\u201d) (NASDAQ: ODT) for violations of the securities laws. The investigation focuses on whether the Company issued false and\/or misleading statements and\/or failed to disclose information pertinent to investors. Odonate\u2019s tesetaxel treatment was not as safe nor as well-tolerated by patients as was touted by the Company. The cancer treatment\u2019s commercial viability was overstated by the Company. Based on these facts, the Company\u2019s public statements … Continue reading "DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Odonate Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-16T13:57:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201116005714r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Odonate Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm\",\"datePublished\":\"2020-11-16T13:57:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/\"},\"wordCount\":314,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201116005714r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/\",\"name\":\"DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Odonate Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201116005714r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2020-11-16T13:57:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201116005714r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201116005714r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Odonate Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Odonate Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/","og_locale":"en_US","og_type":"article","og_title":"DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Odonate Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm - Market Newsdesk","og_description":"DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Odonate Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Odonate Therapeutics, Inc. (\u201cOdonate\u201d or \u201cthe Company\u201d) (NASDAQ: ODT) for violations of the securities laws. The investigation focuses on whether the Company issued false and\/or misleading statements and\/or failed to disclose information pertinent to investors. Odonate\u2019s tesetaxel treatment was not as safe nor as well-tolerated by patients as was touted by the Company. The cancer treatment\u2019s commercial viability was overstated by the Company. Based on these facts, the Company\u2019s public statements … Continue reading \"DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Odonate Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-16T13:57:18+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201116005714r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Odonate Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm","datePublished":"2020-11-16T13:57:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/"},"wordCount":314,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201116005714r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/","name":"DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Odonate Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201116005714r1&sid=flmnd&distro=nx&lang=en","datePublished":"2020-11-16T13:57:18+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201116005714r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201116005714r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-today-the-schall-law-firm-announces-it-is-investigating-claims-against-odonate-therapeutics-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Odonate Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/381764","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=381764"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/381764\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=381764"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=381764"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=381764"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}